Document:

Exhibit 10.8

 

OMNIBUS AMENDMENT AGREEMENT NUMBER TWO 

 

THIS OMNIBUS AMENDMENT
AGREEMENT NUMBER TWO (this “Amendment”), is made as of August 1, 2018, between MaxQ AI Ltd. (formerly known
as MedyMatch Technology Ltd.), a company incorporated under the laws of the State of Israel (the “Company”),
and the purchasers identified on the signature pages hereto (each a “Purchaser” and collectively “Purchasers”)
(including purchasers who acquire Notes and Warrants on or about the date of this Amendment, each a “August Purchaser”
their successors and permitted assigns). Capitalized terms used but not defined herein shall have the meaning ascribed to them
in the SPA (as defined below).

 

WHEREAS, the
Company and South Florida entered into that Certain Securities Purchase Agreement (the “SPA”), Registration
Rights Agreement (the “RRA”) and Security Agreement (Fixed Charge) and Security Agreement (Floating Charge)
(the “Security Agreements”), all dated December 29, 2017, all of the foregoing as amended as of March 23, 2018
pursuant to the Omnibus Amendment Agreement; and

 

WHEREAS, the
Company and the Purchasers signatory hereto constitute the required majority to amend the terms of the SPA and RRA in accordance
with the terms thereof; and

 

WHEREAS, the
Company and Purchasers wish to amend certain provisions of the SPA and RRA and to clarify certain matters of the Security Agreements,
as more thoroughly described herein; and

 

NOW,
THEREFORE, in consideration of the mutual promises and covenants contained herein, the parties hereto hereby agree as follows:

 

		1.	Amendment to the SPA.

 

		1.1.	The definition of “Qualified Offering” shall be replaced in its
entirety with (additions are bold and underlined and deletions are struck through):

 

“Qualified Offering”
means the consummation of a firm commitment initial public offering of the Company’s Ordinary Shares which has an initial
closing (if more than one) not later than September 15, the later of (i) June 30, 2018, at which
initial closing the Company receives not less than $87,000,000 of gross cash proceeds (not including
conversion of the Notes or any other outstanding instrument) at a pre-money valuation of the Company of not less than $50,000,000
on a Fully-Diluted Basis, in connection with which immediately upon the closing the Company’s Ordinary Shares including the
Conversion Shares are listed for trading on a Trading Market and the Ordinary Shares are registered pursuant to Section 12(b) or
Section 12(g) under the Exchange Act, and which offering is made pursuant to a prospectus included in a S-1 registration statement
filed with and declared effective by the Commission.”

 

		1.2.	The definition of “Securities” shall be replaced in its entirety
with (additions are bold and underlined and deletions are struck through):

 

“Securities”
means the Notes, Warrants and the Underlying Shares.”

 

		1.3.	The definition of “Transaction Documents” shall be replaced in
its entirety with (additions are bold and underlined and deletions are struck through):

 

“Transaction
Documents” means this Agreement, the Notes, the Warrants, the Escrow Agreement, each Lockup Agreement,
the Registration Rights Agreement, the Security Agreements, and all exhibits and schedules thereto and hereto.”

 

		1.4.	The definition of “Underlying Shares” shall be replaced in its
entirety with (additions are bold and underlined and deletions are struck through):

 

“Underlying Shares”
means the Ordinary Shares issued and issuable upon conversion of the Notes, and payment of interest on the Notes
in accordance with the terms of the Notes and exercise of the Warrants.”

 

    	 	1	 

     

    

 

		1.5.	The following definitions are included in Section 1.1 of the SPA:

 

“Warrants”
means the Ordinary Share purchase warrants in the form of Exhibit K attached hereto.

 

“Warrant
Shares” means the Ordinary Shares issuable upon exercise of the Warrants, provided that any Ordinary Share issued upon exercise
of the Warrants shall not constitute an issued Warrant Share for purposes of this Agreement after such share has been irrevocably
sold pursuant to an effective registration statement under the Securities Act or pursuant to Rule 144 without further restrictions
or conditions to transfer pursuant to Rule 144.

 

		1.6.	Section 2.1 of the SPA shall be replaced in its entirety with the following
(additions are bold and underlined and deletions are struck through):

 

“2.1
Closing. On the Closing Dates, upon the terms and subject to the conditions set forth herein, the Company agrees to sell,
through Palladium, and the Purchasers, severally and not jointly, agree to purchase, an aggregate of $5,940,000 (inclusive of the
Palladium Notes, as defined below, but exclusive of any amounts in connection with the exercise of the South Florida Option
under Notes issued pursuant to the South Florida Option) of principal amount of Notes, each such purchase and
sale being a “Closing”. An additional Note representing the placement agent fee payable to Palladium as described
on Schedule 3.1(r) will be issued on each Closing Date for the placement agent fee payable to Palladium with respect
to such Closing (each a “Palladium Note” and collectively, “Palladium Notes”), provided
that no fee shall be due with respect to the South Florida Option. The Notes issuable to Palladium will be held by the Escrow Agent
and delivered to Palladium only upon the closing of the Qualified Offering. Each Purchaser shall deliver to the Company such Purchaser’s
Subscription Amount, and the Company shall deliver to each Purchaser its respective Note, and the Company and each Purchaser shall
deliver the other items set forth in Section 2.2 deliverable at a Closing. Upon satisfaction of the covenants and conditions set
forth in Sections 2.2 and 2.3, each Closing shall occur at the offices of Purchaser Counsel or such other location as the parties
shall mutually agree. Notwithstanding anything herein to the contrary, the initial Closing must take place on or before December
27, 2017. The Closing Date for the final Closing shall occur on or before August 1, March 5, 2018
(the “Termination Date”). With respect to any Closing not held on or before the Termination Date, the Escrow
Agent shall cause all subscription documents and funds, if any, to be returned, without interest or deduction to each prospective
Purchaser. Notwithstanding the date of any Closing subsequent to the initial Closing, all time effective clauses in the Transaction
Documents shall commence on the initial Closing Date and the Transaction Documents will be deemed modified mutatis mutandis
in connection with such subsequent Closings, if any, including with respect to the exercise of the South Florida Option. The Maturity
Date (as defined in the Notes) of the Notes issued at all Closings subsequent to the initial Closing shall be the same as the Maturity
Date of the Notes issued at the initial Closing. No sale of Notes may be made pursuant to this Agreement except pursuant to the
Company’s agreement with Palladium as placement agent pursuant to a written agreement between the Company and Palladium.
The South Florida Option may be exercised, in one or more occasions; with respect to Notes issuable pursuant to the South Florida
Option, Exhibit A shall be amended to reflect the Conversion Price per part (e) of the definition of “Exempt Issuance”.

 

		1.7.	Upon closing of an aggregate Subscription Amount of [up to] $1,500,000
for [up to] $1,500,000 principal amount of Notes at or about the date of this Amendment (the “August Closing”), the
Company shall issue to each of the Purchasers identified on Schedule 1.7 hereto an amount of Warrants as set forth on Schedule
1.7 hereto representing the right to acquire “Warrant Shares” (as defined in the Warrant) equal to (i) 100% of the
Conversion Shares issuable upon full conversion of the Notes issued to each Purchaser at or about the date of this Amendment, and
(ii) 25% of the Conversion Shares issuable upon full conversion of the Notes issued to each Purchaser prior to the date of this
Amendment, at the “Exercise Price” defined in the Warrants.

  

    	 	2	 

     

    

 

		1.8.	The parties to this Amendment agree that Disclosure Schedules as of the date
of this Amendment shall be in accordance with amended Schedule 3, which forms part of this Amendment.

 

		1.9.	Schedule 4.16 of the SPA shall be amended and restated as part of
this Amendment, provided that the August Closing shall be conditioned upon (i) delivery of Lock Up Agreements described in Schedule
4.16 as amended and restated hereby executed by Exigent Management Ltd., an Israeli limited liability private company, and/or
any of its Permitted Transferees (as defined in the Company's articles of association) listed on such Schedule 4.16, (ii)
agreement among the parties as to the form of Lock Up Agreement to be executed by the other persons appearing on Schedule 4.16
as amended and restated hereby in favor of ViewTrade Securities, Inc, and (iii) delivery by the August Purchasers of executed Lock
Up Agreements in the form previously delivered by Purchasers prior to the date of this Amendment.

  

		1.10.	Each August Purchaser shall deliver to the Company a completed Investor Questionnaire
in the form annexed to the SPA as Exhibit F.

 

		1.11.	Notwithstanding anything in the SPA or in the
Notes to the contrary, in the event that a Qualified Offering is not consummated  on or prior to September 15, 2018, and
no Event of Default is pending, the Company shall be entitled to raise additional financing which may include borrowed money
that is junior to the Notes pursuant to an intercreditor agreement  acceptable to Holders of a majority of the outstanding
principal amount of the Notes, which borrowed money may or may not be convertible to capital stock of the Company, provided
that in connection with actual or potential issuances of equity the valuation of the Company is not less than $42,500,000 on a
Fully Diluted Basis. 

 

		2.	Amendment to the RRA.

 

		2.1.	The definition of “Initial Registrable Securities”, “Additional
Required Registration Amount”, “Initial Registrable Securities” and “Additional Required Registration Amount”
shall mean zero (0) Ordinary Shares, the intent of the Company and Purchasers being that the Company is relieved of any obligation
to file an Initial Registration Statement or Additional Registration Statement on behalf of the Purchasers, holders of the Warrants
and holders of Private Purchase Shares.

 

		3.	Amendments and clarifications to all the Notes.

 

		3.1.	Subpart (b) of the definition of “Equity Condition” in Section
1 of the Note is deleted and replaced with (additions are bold and underlined and deletions are struck through):

 

“Equity Conditions”
means, at the time in question, unless waived by the Holder, (a) Borrower shall have
paid all liquidated damages and other amounts owing to the applicable Holder in respect of this Note and the other Transaction
Documents, (b) the issuance of the Conversion Shares to the Holder would not exceed the Beneficial Ownership Limitationthere
is an effective registration statement in form and substance consistent with the requirements of the Registration Rights Agreements
pursuant to which, inter alia, the Holders and Investors (as defined in the Purchaser Registration Rights Agreement) are
permitted to utilize the prospectus thereunder to resell all of the Conversion Shares issuable pursuant to the Transaction Documents
and the other Initial Registrable Securities (as defined in the Purchaser Registration Rights Agreement) subject to any lockup
arrangements contemplated by the Transaction Documents and/or entered into by a Holder, and Company counsel has delivered to the
Company’s independent transfer agent in form and substance reasonably acceptable to such transfer agent and Holder a standing,
written opinion that resales may then be made by the Holder of all of the Holders Conversion Shares pursuant to such effective
registration statement, (c) the Ordinary Shares are listed or traded on a Trading Market or approved for listing
or trading on a Trading Market immediately upon the closing of the Qualified Offering, (d) there is a sufficient number of authorized,
but unissued and otherwise unreserved, Ordinary Shares for the issuance of all of the Conversion Shares under all of the Notes,
(e) an Event of Default has not occurred, whether or not such Event of Default has been cured, (f) there is no existing event
which, with the passage of time or the giving of notice, would constitute an Event of Default, (g) there has been no public announcement
of a pending or proposed Fundamental Transaction or Change of Control Transaction that has not been consummated, (h) the applicable
Holder is not in possession of any information provided by Borrower that constitutes, or may constitute, material non-public information
provided to the Holder by the Company, and (i) the Qualified Offering has occurred.”

 

    	 	3	 

     

    

 

		3.2.	The definition of “Qualified Offering” shall be replaced in
its entirety with (additions are bold and underlined and deletions are struck through):

 

“Qualified
Offering” means the consummation of a firm commitment initial public offering of the Borrower’s Ordinary Shares
which has an initial closing (if more than one) not later than September 15the later of (i) June 30,
2018, and (ii) six (6) months after the first Closing Date, at which initial closing the Borrower receives not
less than $87,000,000 of gross cash proceeds (not including conversion of the Notes or any other
outstanding instrument) at a pre-money valuation of the Borrower of not less than $50,000,000 on a Fully-Diluted Basis, in connection
with which immediately upon the closing the Borrower’s Ordinary Shares including the Conversion Shares are listed for trading
on a Trading Market and the Ordinary Shares are registered pursuant to Section 12(b) or Section 12(g) under the Exchange Act, and
which offering is made pursuant to a prospectus included in a S-1 registration statement filed with and declared effective by the
Commission.”

 

		3.3.	The following is included in Section 1 of the Note:

 

“Beneficial
Ownership Limitation shall have the definition given to such term in Section 4(e) of the Note.”

 

		3.4.	Section 4(a) only of the Notes being issued in connection with this Amendment
(“August Notes”) and of no other Notes is deleted and replaced in its entirety with (additions are bold and underlined
and deletions are struck through):

 

“Mandatory
Conversion. Provided all of the Equity Conditions are satisfied prior
to or simultaneously with the Qualified Offering then the outstanding principal and accrued interest on this Note and all of the
Other Notes shall automatically convert without the requirement of any further action on behalf of the Holder, into Ordinary Shares
of the Borrower at a conversion price (the “Conversion Price”) representing the lesser of (i) the pre-money
valuation of the Borrower on a Fully Diluted Basis of $42,500,000 immediately prior to the cashless exercise of any outstanding
Series A warrants of the Company identified in Schedule 3.1(g) to the Purchase Agreement and the Qualified Offering, or (ii) 85%
of the valuation of the Borrower in the Qualified Offering (such conversion being the “Mandatory Conversion”).
In the aggregate, the Conversion Shares issuable to the Holder and Other Holders upon Mandatory Conversion shall represent not
less than the amount of the outstanding equity of the Borrower on a Fully Diluted Basis immediately subsequent to the Mandatory
Conversion as set forth on Schedule 1 hereto, excluding from such calculation shares underlying restricted share units to
be granted to members of senior management of the Borrower in amounts no greater than those shown on Schedule 1. Not later
than the closing of the Qualified Offering, the Borrower will deliver to Holder a certificate from the Borrower’s transfer
agent evidencing the electronic issuance to the Holder of the Conversion Shares on the Borrower’s electronic shareholders
stock ledger maintained by such transfer agent. In the event Borrower fails to deliver to the Holder the foregoing certificate,
the Mandatory Conversion shall not occur. Upon Mandatory Conversion of this Note pursuant to this Section 4, all amounts due hereunder
shall be satisfied, discharged and deemed to have been repaid in full, and any outstanding monetary obligations of the Borrower
towards the Holder hereunder shall be deemed satisfied in full.”

 

    	 	4	 

     

    

 

		3.5.	The following shall be added as Section 4(e) of the Note:

 

“4(e)
Holder’s Conversion Limitations. Borrower shall not effect any conversion of this Note pursuant to Section 4(a) of this Note,
to the extent that after giving effect to the conversion, the Holder (together with the Holder’s Affiliates, and any Persons
acting as a group together with the Holder or any of the Holder’s Affiliates) would beneficially own in excess of the Beneficial
Ownership Limitation (as defined below).  For purposes of the foregoing sentence, the number of Ordinary Shares owned by the
Holder and its Affiliates shall include the number of Ordinary Shares issuable upon conversion of this Note with respect to which
such determination is being made, but shall exclude the number of Ordinary Shares which are issuable upon (i) conversion of the
remaining, unconverted principal amount of this Note beneficially owned by the Holder or any of its Affiliates and (ii) exercise
or conversion of the unexercised or unconverted portion of any other securities of Borrower subject to a limitation on conversion
or exercise analogous to the limitation contained herein (including, without limitation, any other Notes or the Warrants) beneficially
owned by the Holder or any of its Affiliates.  Except as set forth in the preceding sentence, for purposes of this Section
4(e), beneficial ownership shall be calculated in accordance with Section 13(d) of the Exchange Act and the rules and regulations
promulgated thereunder. To the extent that the limitation contained in this Section 4(e) applies, the determination of whether
this Note is convertible (in relation to other securities owned by the Holder together with any Affiliates) and of which principal
and interest amount of this Note is convertible shall be in the sole discretion of the Holder (in relation to other securities
owned by the Holder together with any Affiliates) and which principal and interest amount of this Note is convertible, in each
case subject to the Beneficial Ownership Limitation. In addition, a determination as to any group status as contemplated above
shall be determined in accordance with Section 13(d) of the Exchange Act and the rules and regulations promulgated thereunder.
For purposes of this Section 4(e), in determining the number of outstanding Ordinary Shares, the Holder may rely on the number
of outstanding Ordinary Shares as stated in the most recent of the following: (i) Borrower’s most recent periodic or annual
report filed with the Commission, as the case may be, (ii) a more recent public announcement by Borrower, or (iii) a more recent
written notice by Borrower or Borrower’s transfer agent setting forth the number of Ordinary Shares outstanding.  Upon
the written or oral request of a Holder, Borrower shall within two Business Days confirm orally and in writing to the Holder the
number of Ordinary Shares then outstanding.  In any case, the number of outstanding Ordinary Shares shall be determined after
giving effect to the conversion or exercise of securities of Borrower, including this Note, by the Holder or its Affiliates since
the date as of which such number of outstanding Ordinary Shares was reported. The “Beneficial Ownership Limitation”
shall be 9.99% of the number of shares of the Common Stock outstanding immediately after giving effect to the issuance of Ordinary
Shares issuable upon conversion of this Note held by the Holder. The Beneficial Ownership Limitation provisions of this Paragraph
4(e) shall be construed and implemented in a manner otherwise than in strict conformity with the terms of this Section 4(e) to
correct this paragraph (or any portion hereof) which may be defective or inconsistent with the intended Beneficial Ownership Limitation
contained herein or to make changes or supplements necessary or desirable to properly give effect to such limitation. The limitations
contained in this paragraph shall apply to a successor holder of this Note. In the event all or a portion of the Note may not be
converted pursuant to Section 4(a) due to Equity Condition (b), then the amount that may be mandatorily converted without exceeding
the Beneficial Ownership Limitation will be converted and the remaining unconverted portion of the Note will be converted by the
Borrower promptly after such unconverted portion may be converted without exceeding the Beneficial Ownership Limitation.”

 

    	 	5	 

     

    

 

		4.	Clarification with respect to the Security Agreements

 

		4.1.	The parties hereby agree that any additional Notes to be issued pursuant
to the June Closing shall be deemed Notes under the Security Agreements and the Purchasers and the Company shall cause to be made
at the Company’s expense all filings necessary or appropriate to memorialize and protect the rights of Purchasers under the
Security Agreements.

 

		5.	Fees and Expenses.

 

		5.1.	Each party hereto shall pay all costs and expenses that it incurs with respect
to the negotiation, execution, delivery and performance of this Amendment; provided that subject to consummation of an additional
Closing under the SPA, the Company shall pay the costs actually incurred by Palladium in connection with the investment contemplated
by the SPA and this Amendment (including legal costs), up to the maximum amount of US$18,500. Reimbursement may be made by way
of direct payment to Palladium’s advisors.

 

		6.	Additional Investment.

 

		6.1.	Each of the Purchasers identified on the signature pages hereto hereby subscribes
for the amount of June Note Principal set forth beneath such Purchaser’s signature. The Company and each Purchaser for itself
will take such actions and enter into additional agreements necessary to effectuate the foregoing subscription to purchase June
Notes.

 

		7.	Escrow.

 

		7.1.	Escrow Closing. The parties hereto agree that a Closing with respect
to the June Notes may take place directly between the parties hereto and not pursuant to the Escrow Agreement.

 

		8.	Miscellaneous.

 

		8.1.	Governing Law. All questions concerning the construction, validity,
enforcement and interpretation of this Amendment (other than those mandatorily subject to Israeli law and which may not be waived
under Israeli law) shall be governed by and construed and enforced in accordance with the internal laws of the State of New York,
without regard to the principles of conflicts of law thereof except as to corporate law matters which are specifically required
by the laws of the State of Israel to be governed by the laws of the State of Israel.

 

		8.2.	Entire Agreement. This Amendment together with the SPA, Security Agreements
and all exhibits and ancillaries hereto and thereto, constitute the full and entire agreement, covenants, promises and understandings
between the parties hereto with respect to the subject matter hereof, and supersede any and all prior agreements, understandings,
promises and representations made by all or some of the parties (or by either party to the other), written or oral, concerning
the subject matter hereof and the terms applicable hereto. In the event of inconsistency between the terms of this Amendment and
the Security Agreements, the terms of this Amendment shall prevail.

 

		8.3.	Amendment & Waivers. Any term of this Amendment may be amended
and the severance of any term hereof may be waived (either generally or in a particular instance and either retroactively or prospectively)
only with the written consent of the Company, the Purchasers representing the Majority in Interest under the SPA.

 

		8.4.	Counterparts This Amendment may be executed by multiple counterparts
(including facsimile counterparts), each of which shall be original as against the party whose signature appears thereon, but all
of which taken together shall constitute one and the same instrument.

 

[REST OF THIS PAGE LEFT INTENTIONALLY BLANK]

 

    	 	6	 

     

    

 

IN WITNESS WHEREOF,
the parties hereto have caused this Omnibus Amendment Agreement Number Two to be duly executed by their respective authorized signatories
as of the date first indicated above.

 

COMPANY:

 

	MaxQ AI Ltd.	 	 
	 	 	 
	/s/ Michael Rosenberg	 	 
	By: 	Michael Rosenberg	 	 
	Its: 	Chief Financial Officer	 	 
	 	 	 
	PURCHASERS:	 	 
	 	 	 
	South Florida Biotech Ventures LLC	 	 
	 	 	 
	/s/ Mark Groussman	 	 
	By: 	Mark Groussman	 	 
	Its: 	Managing Member	 	 
	Principal August Note Subscription Amount:	$	 
	 	 	 
	HS CONTRARIAN INVESTMENTS LLC	 	 
	 	 	 
	/s/ John Stetson	 	 
	By: 	John Stetson	 	 
	Its: 	Managing Member	 	 
	Principal August Note Subscription Amount:	$	 
	 	 	 
	ALPHA CAPITAL ANSTALT	 	 
	 	 	 
	/s/ Konrad Ackermann	 	 
	By: Konrad Ackermann	 	 
	Its: Director	 	 
	Principal August Note Subscription Amount: 	$	 
	 	 	 
	MELECHDAVID, INC.	 	 
	 	 	 
	/s/
                                         Mark Groussman

	 	 
	By: 	Mark Groussman	 	 
	Its: 	President	 	 
	Principal August Note Subscription Amount: 	$	 
	 	 	 
	ACKNOWLEDGED AND AGREED:	 	 
	 	 	 
	GRUSHKO & MITTMAN, P.C. AS	 	 
	ESCROW AGENT	 	 
	 	 	 
	/s/ Grushko & Mittman, P.C.	 	 
	By:	 Edward M. Grushko

	 	 

 

[MaxQ AI Ltd. / Signature Page to Omnibus
Amendment Agreement Number Two] 

 

    	 	7	 

     

    

 

IN WITNESS WHEREOF,
the parties hereto have caused this Omnibus Amendment Agreement Number Two to be duly executed by their respective authorized signatories
as of the date first indicated above.

 

	AUGUST
    PURCHASERS:	 
	 	 
	ANDREW
    SCHWARTZBERG	 
	 	 
	/s/
    Andrew Scwartzberg	 
	Principal
                                         August Note Subscription Amount: $650,000

	 
	 	 
	BRIAN
    WEITMAN	 
	 	 
	/s/
    Brian Weitman	 
	Principal
    August Note Subscription Amount: $100,000	 
	 	 
	ALPHA
    CAPITAL ANSTALT	 
	 	 
	/s/
    Konrad Ackermann	 
	By:
    Konrad Ackermann	 
	Its:
    Director	 
	Principal
    August Note Subscription Amount: $250,000	 
	 	 
	CPMHB
    LLC	 
	 	 
	/s/
    Christian Paez	 
	By:
    Christian Paez	 
	Its:
    Manager	 
	Principal
    August Note Subscription Amount: $300,000	 

 

 

[MaxQ AI Ltd. / Signature Page to Omnibus
Amendment Agreement Number Two]

 

    	 	8Exhibit 10.9

 

OMNIBUS
AMENDMENT AGREEMENT NUMBER THREE 

 

THIS
OMNIBUS AMENDMENT AGREEMENT NUMBER THREE (this “Amendment”), is made as of August 7, 2018, between MaxQ AI
Ltd. (formerly known as MedyMatch Technology Ltd.), a company incorporated under the laws of the State of Israel (the “Company”),
and the purchasers identified on the signature pages hereto (each a “Purchaser” and collectively “Purchasers”).
Capitalized terms used but not defined herein shall have the meaning ascribed to them in the SPA (as defined below).

 

WHEREAS,
the Company and South Florida entered into that Certain Securities Purchase Agreement (the “SPA”), Registration
Rights Agreement (the “RRA”) and Security Agreement (Fixed Charge) and Security Agreement (Floating Charge)
(the “Security Agreements”), all dated December 29, 2017, all of the foregoing as amended as of March 23, 2018
pursuant to the Omnibus Amendment Agreement and as of August 1, 2018 pursuant to Omnibus Agreement Number Two; and

 

WHEREAS,
the Company and the Purchasers signatory hereto constitute the required majority to amend the terms of the SPA and RRA in accordance
with the terms thereof; and

 

WHEREAS,
the Company and Purchasers wish to amend certain provisions of the SPA and RRA and to clarify certain matters of the Security
Agreements, as more thoroughly described herein; and

 

NOW,
THEREFORE, in consideration of the mutual promises and covenants contained herein, the parties hereto hereby agree as follows:

 

		1.	Amendment
                                         to the SPA and other Transaction Documents.

 

		1.1.	The
                                         definition of “Qualified Offering” in the SPA and each other place in which
                                         it appears in the other Transaction Documents shall be amended by the replacement of
                                         the number “$8,000,000” with the number “$7,000,000”.

 

		2.	Miscellaneous.

 

		2.1.	Governing
                                         Law. All questions concerning the construction, validity, enforcement and interpretation
                                         of this Amendment (other than those mandatorily subject to Israeli law and which may
                                         not be waived under Israeli law) shall be governed by and construed and enforced in accordance
                                         with the internal laws of the State of New York, without regard to the principles of
                                         conflicts of law thereof except as to corporate law matters which are specifically required
                                         by the laws of the State of Israel to be governed by the laws of the State of Israel.

 

		2.2.	Entire
                                         Agreement. This Amendment together with the SPA, Security Agreements and all exhibits
                                         and ancillaries hereto and thereto, constitute the full and entire agreement, covenants,
                                         promises and understandings between the parties hereto with respect to the subject matter
                                         hereof, and supersede any and all prior agreements, understandings, promises and representations
                                         made by all or some of the parties (or by either party to the other), written or oral,
                                         concerning the subject matter hereof and the terms applicable hereto. In the event of
                                         inconsistency between the terms of this Amendment and the Security Agreements, the terms
                                         of this Amendment shall prevail.

 

		2.3.	Amendment
                                         & Waivers. Any term of this Amendment may be amended and the severance of any
                                         term hereof may be waived (either generally or in a particular instance and either retroactively
                                         or prospectively) only with the written consent of the Company, the Purchasers representing
                                         the Majority in Interest under the SPA.

 

		2.4.	Counterparts
                                         This Amendment may be executed by multiple counterparts (including facsimile counterparts),
                                         each of which shall be original as against the party whose signature appears thereon,
                                         but all of which taken together shall constitute one and the same instrument.

 

[REST
OF THIS PAGE LEFT INTENTIONALLY BLANK]

 

     

     

    

 

IN
WITNESS WHEREOF, the parties hereto have caused this Omnibus Amendment Agreement Number Three to be duly executed by their
respective authorized signatories as of the date first indicated above.

 

COMPANY:

 

MaxQ
AI Ltd. 

 

	/s/ Michael Rosenberg	 
	By:	Michael Rosenberg	 
	Its:	Chief Financial Officer	 

  

PURCHASERS:

 

South
Florida Biotech Ventures LLC

 

	/s/ Mark Groussman	 
	By:	Mark Groussman	 
	Its:	Managing Member	 

 

HS
CONTRARIAN INVESTMENTS LLC

 

	/s/ John Stetson	 
	By:	John Stetson	 
	Its:	Manager	 

 

ALPHA
CAPITAL ANSTALT

 

	/s/ Konard Ackerman	 
	By:	Konard Ackerman	 
	Its:	Director	 

 

MELECHDAVID,
INC.

 

	/s/ Mark Groussman	 
	By:	Mark Groussman	 
	Its:	 	 

 

ACKNOWLEDGED
AND AGREED:

 

GRUSHKO
& MITTMAN, P.C. AS

ESCROW
AGENT

 

	By:	 	 

 

[MaxQ
AI Ltd. / Signature Page to Omnibus Amendment Agreement Number Three] 

 

    	 	2	 

     

    

 

IN
WITNESS WHEREOF, the parties hereto have caused this Omnibus Amendment Agreement Number Three to be duly executed by their
respective authorized signatories as of the date first indicated above.

  

	ANDREW SCHWARTZBERG	 
	 	 
	/s/ Andrew Schwartzberg	 
	 	 
	BRIAN WEITMAN	 
	 	 
	/s/ Brian Weitman	 

 

CPMHB
LLC

 

	/s/ Christian Paez	 
	By:	Christian Paez	 
	Its:	Manager	 

 

[MaxQ
AI Ltd. / Signature Page to Omnibus Amendment Agreement Number Three]

 

    	 	3

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00286-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00286-of-00352.parquet"}]]